XOLAIR
Live / Registered — Registered (as of 27 Jun 2023)
What this means for you
Registered since 27 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90794951
- Registration number
- 7094379
- Mark type
- Stylized text
- Filed
- 25 Jun 2021
- Published for opposition
- 26 Apr 2022
- Registered
- 27 Jun 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of chronic rhino sinusitis with nasal polyps
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 27 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 May 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 May 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Mar 2023 — USE AMENDMENT FILED
- 10 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Mar 2023 — TEAS STATEMENT OF USE RECEIVED
- 20 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2022 — SOU EXTENSION 1 GRANTED
- 18 Dec 2022 — SOU EXTENSION 1 FILED
- 18 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Apr 2022 — PUBLISHED FOR OPPOSITION